Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Studies of the efficacy and safety of methotrexate (MTX) at dosages over 8 mg/week using the IORRA cohort database


  • Please log in to reply
No replies to this topic

#1 Jeannie McClelland

Jeannie McClelland

    Senior Gold Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 1,706 posts
  • Location:in the Rocky Mountains of the USA

Posted 30 April 2011 - 08:33 AM

Studies of the efficacy and safety of methotrexate (MTX) at dosages over 8 mg/week using the IORRA cohort database The results indicated that MTX dosages over 8 mg/week did not have any association with either severe or severe + moderate side-effects. Yohei Seto, Modern Rheumatology, 20 March 2011 (Also see: Methotrexate)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Jeannie McClelland
(Retired) ISN Director of Support Services
(Retired) ISN Sclero Forums Manager
(Retired) ISN Blog Manager
(Retired) ISN Assistant News Guide
(Retired) ISN Artist
International Scleroderma Network